Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- QFIN -13.7%, WIX -3.9%, DLB -3.4%, GLBE -3.4%, TGT -2.1%
Other news:
- AGIO -34.3% (topline results from RISE UP Phase 3 Trial of mitapivat in sickle cell disease; Trial showed trend favoring mitapivat but did not meet statistical significance in primary endpoint)
- PLUG -19.2% (convertible notes offering)
- ECO -8.2% (has announced a contemplated offering of new common shares)
- NOK -6.5% (announces new strategy, evolution of its operating model, new long-term financial target, strategic KPIs and changes to its group leadership team)
- OGS -5.1% (Board Chair retires, names new Chair)
- EOSE -3.6% (convertible notes offering; also proposed direct offering of common stock to fund repurchase of convertible notes)
- OLMA -2.2% (prices public offering of 10.0 mln shares of common stock at $19/share)
- ELDN -1.9% (data from early patients treated with Tegoprubart)